<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: At present, the relationship between Nanog expression and the biological behavior and prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is still unclear </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: The purpose of this study was to evaluate the expression and regulatory effects of Nanog in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and the correlation between Nanog protein expression and the prognosis of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: The differential expression of genes between CD133+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and CD133- <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells were detected using RT(2) Profilerâ„¢ PCR Array </plain></SENT>
<SENT sid="3" pm="."><plain>The Nanog <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level was detected by RT-PCR and the protein level was detected using immunohistochemistry staining </plain></SENT>
<SENT sid="4" pm="."><plain>The relationship between Nanog expression and clinicopathological parameters of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Nanog were expressed significantly higher in CD133+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells compared to CD133- <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>It was observed that 72 (20.00 %) of the 360 cases positively expressed Nanog </plain></SENT>
<SENT sid="7" pm="."><plain>Univariate analyses indicated that Nanog expression was related to histological grade, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, TNM stage, and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (P = 0.005, 0.001, 0.001 and 0.012, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Spearman correlation analysis showed that Nanog expression has a linear correlation to <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (P = 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>After conducting multivariate analysis, histological grade, TNM stage, and Nanog were found to be related to <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (P = 0.020, 0.01 and 0.001, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>In the Cox regression test, the histological grade, Lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, TNM stage, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, and Nanog were detected as the independent prognostic factors (P = 0.02, 0.045, 0.01, 0.001 and 0.001, respectively) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Nanog protein may be a potential biomarker for postoperative <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>